======= TAF11 ======= == Gene Information == * **Official Symbol**: TAF11 * **Official Name**: TATA-box binding protein associated factor 11 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6882|6882]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15544|Q15544]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF11&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF11|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600772|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Core TAFII present in both of the previously described TFIID species which either lack or contain TAFII30 (TFIID alpha and TFIID beta respectively). |TAFII28| |CBFD NFYB HMF| |RNA polymerase II preinitiation complex assembly| |vitamin D receptor binding| |positive regulation by host of viral transcription| |transcription preinitiation complex assembly| |thyroid hormone receptor binding| |transcription factor TFIID complex| |positive regulation of viral transcription| |regulation of viral transcription| |snRNA transcription by RNA polymerase II| |modification by host of symbiont morphology or physiology| |snRNA transcription| |interaction with symbiont| |ncRNA transcription| |protein N-terminus binding| |positive regulation of viral process| |modification of morphology or physiology of other organism involved in symbiotic interaction| |modification of morphology or physiology of other organism| |transcription initiation from RNA polymerase II promoter| |regulation of signal transduction by p53 class mediator| |protein-DNA complex assembly| |regulation of viral process| |DNA-templated transcription, initiation| |regulation of symbiosis, encompassing mutualism through parasitism| |protein-DNA complex subunit organization| |transcription coactivator activity| |transcription factor binding| |transcription by RNA polymerase II| |protein heterodimerization activity| |positive regulation of multi-organism process| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of multi-organism process| |symbiotic process| |interspecies interaction between organisms| |cellular protein-containing complex assembly| |Golgi apparatus| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |DNA binding| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.93| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.77| |[[:results:exp443|SNS-032 15μM R08 exp443]]|1.74| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.83| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.88| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|2.21| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|2.26| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|2.62| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|3.04| ^Gene^Correlation^ |[[:human genes:t:thg1l|THG1L]]|0.438| |[[:human genes:d:dohh|DOHH]]|0.423| |[[:human genes:t:taf13|TAF13]]|0.408| |[[:human genes:g:gtf3c4|GTF3C4]]|0.405| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4036 * **Expression level (log2 read counts)**: 5.56 {{:chemogenomics:nalm6 dist.png?nolink |}}